Sana Biotechnology SANA
NASDAQ SANA
$2.35 -0.01 (-0.42%)
At close: Oct 21, 2026 · 4:00 PM EDT

Sana Biotechnology (SANA) Total Non-Current Liabilities (2020 - 2026)

Updated

Sana Biotechnology's Total Non-Current Liabilities came in at $177.35 million for Q2 2026, up 45.4% from $121.96 million a year earlier and up 3.6% from the prior quarter.

Analysis

Sana Biotechnology (SANA) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Sana Biotechnology's Total Non-Current Liabilities was $172.49 million, up 21.9% from FY2024.

  • Total Non-Current Liabilities carries a five-year compound annual growth rate of -30.0% (FY2020 to FY2025).
  • Going back by year, Total Non-Current Liabilities was $141.55 million in FY2024 (-15.8%), $168.19 million in FY2023 (-26.4%), $228.37 million in FY2022 (-23.5%) and $298.54 million in FY2021 (-71.0%).
  • The Q2 2026 figure represents the highest quarterly Total Non-Current Liabilities since Q1 2024.
  • Year-over-year, Total Non-Current Liabilities has increased for three consecutive quarters, with growth averaging 0.3% over the last eight quarters.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q2 2026 (growth of 45.4%), and the weakest in Q4 2021 (a decline of 71.0%).
  • Business Quant data shows SANA's Total Non-Current Liabilities at $171.15 million (Q1 2026), $172.49 million (Q4 2025) and $124.98 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 106.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.10 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 97.04 Bn
10 Sana Biotechnology 694.82 Mn 141.76 Mn - 107.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 107.86 Mn
Mar 31, 2026 80.44 Mn
Dec 31, 2025 161.89 Mn
Sep 30, 2025 53.21 Mn
Jun 30, 2025 47.82 Mn
Mar 31, 2025 56.52 Mn
Dec 31, 2024 131.65 Mn
Sep 30, 2024 87.00 Mn
Jun 30, 2024 99.70 Mn
Mar 31, 2024 127.55 Mn
Dec 31, 2023 168.19 Mn
Sep 30, 2023 110.53 Mn
Jun 30, 2023 138.30 Mn
Mar 31, 2023 115.45 Mn
Dec 31, 2022 228.37 Mn
Sep 30, 2022 250.38 Mn
Jun 30, 2022 233.59 Mn
Mar 31, 2022 243.64 Mn
Dec 31, 2021 298.54 Mn
Sep 30, 2021 232.91 Mn
API Access

Sana Biotechnology Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SANA&period=max&api_key=YOUR_API_KEY